Chimeric Antigen Receptor-Engineered T Cell Therapy for the Management of Patients with Metastatic Prostate Cancer: A Comprehensive Review

Prostate cancer (PCa) has a vast clinical spectrum from the hormone-sensitive setting to castration-resistant metastatic disease. Thus, chemotherapy regimens and the administration of androgen receptor axis-targeted (ARAT) agents for advanced PCa have shown limited therapeutic efficacy. Scientific a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Young Dong, Kim, Tae Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826945/
https://www.ncbi.nlm.nih.gov/pubmed/33440664
http://dx.doi.org/10.3390/ijms22020640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826945/
https://www.ncbi.nlm.nih.gov/pubmed/33440664
http://dx.doi.org/10.3390/ijms22020640

Ejemplares similares